137 related articles for article (PubMed ID: 22684066)
1. Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.
Unno M; Kizawa K; Ishihara M; Takahara H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jun; 68(Pt 6):668-70. PubMed ID: 22684066
[TBL] [Abstract][Full Text] [Related]
2. Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type I.
Unno M; Kinjo S; Kizawa K; Takahara H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1357-9. PubMed ID: 24316829
[TBL] [Abstract][Full Text] [Related]
3. Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V.
Arita K; Hashimoto H; Shimizu T; Yamada M; Sato M
Acta Crystallogr D Biol Crystallogr; 2003 Dec; 59(Pt 12):2332-3. PubMed ID: 14646111
[TBL] [Abstract][Full Text] [Related]
4. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
[TBL] [Abstract][Full Text] [Related]
5. Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.
Saijo S; Nagai A; Kinjo S; Mashimo R; Akimoto M; Kizawa K; Yabe-Wada T; Shimizu N; Takahara H; Unno M
J Mol Biol; 2016 Jul; 428(15):3058-73. PubMed ID: 27393304
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.
Rechiche O; Lee TV; Lott JS
Acta Crystallogr F Struct Biol Commun; 2021 Oct; 77(Pt 10):334-340. PubMed ID: 34605437
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary X-ray crystallographic analysis of human myotubularin-related protein 1.
Bong SM; Yang SW; Choi JW; Kim SJ; Lee BI
Acta Crystallogr F Struct Biol Commun; 2015 Mar; 71(Pt 3):261-5. PubMed ID: 25760698
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
9. Expression, crystallization and preliminary X-ray crystallographic studies of Arthrobacter globiformis inulin fructotransferase.
Momma M; Fujimoto Z; Maita N; Haraguchi K; Mizuno H
Acta Crystallogr D Biol Crystallogr; 2003 Dec; 59(Pt 12):2286-8. PubMed ID: 14646096
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
11. Overexpression, purification, crystallization and preliminary X-ray crystallographic analysis of Pseudomonas aeruginosa L-arginine deiminase.
Oudjama Y; Tricot C; Stalon V; Wouters J
Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2150-2. PubMed ID: 12454483
[TBL] [Abstract][Full Text] [Related]
12. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and preliminary X-ray diffraction analysis of a fatty-acid metabolism regulatory protein, FadR, from Bacillus halodurans.
Park YW; Yeo HK; Lee JY
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Aug; 68(Pt 8):975-7. PubMed ID: 22869136
[TBL] [Abstract][Full Text] [Related]
14. Crystallization and preliminary X-ray diffraction studies of the precursor protein of a thermostable variant of papain.
Roy S; Choudhury D; Chakrabarti C; Biswas S; Dattagupta JK
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 May; 67(Pt 5):634-6. PubMed ID: 21543879
[TBL] [Abstract][Full Text] [Related]
15. Crystallization and preliminary X-ray analysis of cecropin B from Bombyx mori.
Liu Z; Zhou Q; Mao X; Zheng X; Guo J; Zhang F; Wen T; Pang H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jul; 66(Pt 7):851-3. PubMed ID: 20606290
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.
Ranaivoson FM; Bande R; Cardaun I; De Riso A; Gärtner A; Loke P; Reinisch C; Vogirala P; Beaumont E
IUCrJ; 2024 May; 11(Pt 3):395-404. PubMed ID: 38656308
[TBL] [Abstract][Full Text] [Related]
17. Production, crystallization and structure determination of a mycobacterial glucosylglycerate hydrolase.
Cereija TB; Alarico S; Empadinhas N; Pereira PJB
Acta Crystallogr F Struct Biol Commun; 2017 Sep; 73(Pt 9):536-540. PubMed ID: 28876234
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
19. Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.
Zhao C; Ling B; Dong L; Liu Y
Proteins; 2017 Aug; 85(8):1518-1528. PubMed ID: 28486790
[TBL] [Abstract][Full Text] [Related]
20. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
